
Overview
Teva Operations Poland operates in the pharmaceutical industry, covering generic and specialty medicines. Teva runs a manufacturing plant in Krakow, marking its 95th anniversary in 2026, and educational campaigns about migraine and bone health.
Financials
Revenue history (in m)
Filing timeliness
2 of 6 financial statements were filed late (the longest delay 84 days for 2021). 5 of 6 audited by a statutory auditor.
- 202513/08/2026
- 202404/07/2025
- 202308/07/2024
- 202211/07/2023
- 202107/10/2022
- 202012/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
- teva.plLeki generyczne i specjalistyczne | firma farmaceutyczna TevaGoogle Tag ManagerCloudflare
Trademarks
The company holds 78 active trademarks registered with the Polish Patent Office. 235 marks have expired or were not registered. The first mark was filed in 1969.
| Mark | Protected until | |
|---|---|---|
| FLEGAMINA FAST JUNIOR (word) | Oct 6, 2032 | |
| FLEGAMINA FAST (word) | Oct 6, 2032 | |
| METFORMAX COMBI (word) | Jan 21, 2032 | |
| SUPREMIN COMFORT (word) | Mar 23, 2030 | |
| SUPREMIN MAX (word) | Mar 23, 2030 |
Job offers
The company has its own careers page: teva.pl/youcareer.
Authorized Representatives
Manner of representation
In the case of a multi-member management board, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Pliva Hrvatska D.o.o. | 101 | $6,002,160.99 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Sanctions and PEP
Sanctions
No matches (EU, UN, US, UK, MSWiA, World Bank)
PEP
No matches
Bank accounts
Registered as a VAT taxpayer on 2003-12-31.
38 1030 1508 0000 0008 1534 2003
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $925.2K$925,194 |
Buildings and premises | $23.6M$23,607,859 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jul 19, 2011 | Commercial Companies Code notice | |
| May 9, 2011 | Merger plan |
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 26, 2017 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | $11,704$11,704 | Prezydent Miasta Kraków |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Adamed Pharma S.A. | $541,927,181.76 | adamed.com.pl | ||
| Astrazeneca Pharma Poland sp. z o.o. | $466,142,370.29 | astrazeneca.pl | ||
| Bausch Health Poland sp. z o.o. | $433,316,311.35 | bauschhealthpoland.pl | ||
| Fresenius Kabi Polska sp. z o.o. | $247,097,438.47 | fresenius-kabi.com | ||
| Bristol-Myers Squibb Polska sp. z o.o. | $230,722,737.87 | bms.com | ||
| Takeda Pharma sp. z o.o. | $246,400,594.27 | takeda.com | ||
| Zentiva Polska sp. z o.o. | $134,295,523.17 | zentiva.pl | ||
| Przedsiębiorstwo Farmaceutyczne Lek-Am sp. z o.o. | $102,266,019.67 | lekam.pl | ||
| Sandoz Polska sp. z o.o. | $89,136,265.74 | sandoz.com | ||
| Polfarmex S.A. | $73,543,379.32 | polfarmex.pl |
Change history
| Date | Event | |
|---|---|---|
| 2012-11-08 | Share capital increase (22,000,000.00 PLN → 22,220,000.00 PLN) | |
| 2011-07-01 | Address change (Poleczki Budynek Platan Park II Wejście H 23, 02-822, Warszawa → Emilii Plater 53, 00-113, Warszawa) | |
| 2011-04-07 | Name change (Ratiopharm Polska → Teva Operations Poland) | |
| 2006-11-14 | Share capital increase (17,000,000.00 PLN → 22,000,000.00 PLN) | |
| 2006-09-21 | Address change (Powsińska 4, 02-920, Warszawa → Poleczki Budynek Platan Park II Wejście H 23, 02-822, Warszawa) |
FAQ
Last updated: 2026-10-07